• / Free eNewsletters & Magazine
  • / My Account
Home>Stocks>Sanofi-Aventis ADR

Sanofi-Aventis ADR

  1. All
  2. Morningstar Articles
  3. Videos
  4. Investing
  1. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  2. Funds That Buy Like Buffett 2015

    Funds that emulate the Oracle of Omaha have done well over time.

  3. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    These top managers continue to focus on higher-quality dividend-paying stocks in a market that has become more volatile of late.

  4. Our 2014 Big Pharma Pipeline Rankings: Who Came Out on Top?

    Merck's reinvigorated pipeline and Sanofi's minimal patent-loss exposure placed them atop our rankings this year, while GlaxoSmithKline joined Pfizer toward the bottom.

  5. 5 Wide-Moat Stocks That Were Left Behind in 2014

    It was a good year for wide-moat stocks overall, but Exxon, Amazon, and a few others lagged the market, says Morningstar markets editor Jeremy Glaser.

  6. Top 10 Purchases and Sales from Our Ultimate Stock-Pickers

    A group of top managers remains cautious and commits more capital to traditional defensive sectors, while taking advantage of a rising (and potentially overvalued) market to book some gains.

  7. Health Care a Leader in Moat Stocks

    The health-care sector has a higher volume of moat firms compared with other industries, and companies' patent and brand power deliver very strong returns on capital.

  8. The Ultimate Stock-Pickers’ Top 10 Dividend Stocks

    Top managers continue to focus on higher-quality dividend-paying stocks in a fully valued market.

  9. Makings of a Wide Moat in Diabetes Care

    Novel products will allow drug firms to achieve price premiums on diabetes drugs in the U.S. and at least retain level pricing internationally.

  10. Funds That Buy Like Buffett, 2014

    These funds emulate the Oracle of Omaha in many ways.

12345
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.